Kirin Holdings Co. (OTCMKTS:KNBWY) Sees Large Growth in Short Interest

Key Points

• Kirin Holdings Co. experienced a significant increase in short interest, rising by 124.2% to a total of 93,500 shares as of September 30th.
• The company's stock price reached $14.70 with a market capitalization of $11.91 billion and a price-to-earnings ratio of 32.67.
• Kirin reported $0.24 EPS for the last quarter, falling short of the consensus estimate of $0.28 EPS.

Kirin Holdings Co. (OTCMKTS:KNBWY - Get Free Report) was the target of a large growth in short interest in September. As of September 30th, there was short interest totaling 93,500 shares, a growth of 124.2% from the September 15th total of 41,700 shares. Based on an average daily volume of 63,300 shares, the days-to-cover ratio is currently 1.5 days. Based on an average daily volume of 63,300 shares, the days-to-cover ratio is currently 1.5 days.

Kirin Stock Performance

Shares of OTCMKTS:KNBWY traded up $0.01 on Monday, reaching $14.70. 27,948 shares of the company's stock were exchanged, compared to its average volume of 62,045. Kirin has a twelve month low of $12.25 and a twelve month high of $15.70. The company has a fifty day moving average of $14.67 and a 200-day moving average of $14.40. The company has a market capitalization of $11.91 billion, a price-to-earnings ratio of 32.67 and a beta of 0.13. The company has a current ratio of 1.26, a quick ratio of 0.82 and a debt-to-equity ratio of 0.58.

Kirin (OTCMKTS:KNBWY - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.28 by ($0.04). Kirin had a net margin of 2.30% and a return on equity of 3.75%. The company had revenue of $4.01 billion during the quarter, compared to the consensus estimate of $608.48 billion. On average, research analysts predict that Kirin will post 1.12 EPS for the current fiscal year.

About Kirin

Kirin Holdings Company, Limited engages in food and beverages, pharmaceuticals, and health science businesses. The company's products include beer, wine, whiskey, spirits, soft drinks, dairy products, and other products. It also produces and sells pharmaceutical products, biochemical products, and other products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.